<?xml version="1.1" encoding="utf-8"?>
<article xsi:noNamespaceSchemaLocation="http://jats.nlm.nih.gov/publishing/1.1/xsd/JATS-journalpublishing1-mathml3.xsd" dtd-version="1.1" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><front><journal-meta><journal-id journal-id-type="publisher-id">OTD</journal-id><journal-title-group><journal-title>Oncology Treatment Discovery</journal-title></journal-title-group><issn>3083-4996</issn><eissn>2981-8079</eissn><publisher><publisher-name>Bio-Byword Scientific Publishing Pty. Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.26689/otd.v3i3.12075</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title>Investigation of Potential Biological Mechanisms Linking Blood Lipids and Head and Neck Squamous Cell Carcinoma</title><url>https://artdesignp.com/journal/OTD/3/3/10.26689/otd.v3i3.12075</url><author>ZhouAoxiong,ChenJiahao,OuYumeng,WuJinhai</author><pub-date pub-type="publication-year"><year>2025</year></pub-date><volume>3</volume><issue>3</issue><history><date date-type="pub"><published-time>2025-10-16</published-time></date></history><abstract>Background: Head and neck squamous cell carcinoma (HNSCC) is a common malignancy with a heterogeneous etiology. Circulating total cholesterol (TC), apolipoprotein A-I (ApoA-I), and low-density lipoprotein cholesterol (LDL-C) may influence tumorigenesis via metabolic, inflammatory, and immune pathways. The causal relationship and molecular mechanisms remain unclear. This study systematically evaluated lipid-related genetic variants and HNSCC risk. Methods: Two-sample Mendelian randomization (MR) using genome-wide association study (GWAS) data assessed causal effects of TC, ApoA-I, and LDL-C on head and neck cancer (HNC). Significant single-nucleotide polymorphisms (SNPs) were functionally annotated and subjected to pathway enrichment. Candidate genes were analyzed in GEPIA2, TIMER3.0, and cBioPortal for differential expression (DE), survival, immune infiltration, and clinical stage associations. Results: MR revealed no significant causal effects (P&amp;gt;0.05). Positive effect group SNPs are enriched in cytochrome P450 (CYP450)-mediated xenobiotic metabolism; negative effect group SNPs are enriched in monocarboxylic acid and alcohol metabolism pathways, suggesting protective metabolic adaptation. DE analysis showed ADH1B downregulation and FADS1/2, PARP9, and SEMA7A upregulation. Immune infiltration linked these genes to CD8⁺ T cells, M1/M2 macrophages, regulatory T cells (Treg), cancer-associated fibroblasts (CAF), and NK cells, with ADH1B downregulation associated with immunotherapy response. ALDH1A2, EVI5, and LCAT, though not DE, exhibited prognostic value, with expression increasing in advanced stages. Conclusion: Lipid-related variants may influence HNSCC via opposing mechanisms: CYP450/inflammation versus metabolic adaptation/alcohol pathways. ADH1B and FADS1/2, PARP9, SEMA7A regulate tumor metabolism and immune microenvironment; ALDH1A2, EVI5, and LCAT hold prognostic potential. These findings provide mechanistic insight and candidate molecular targets for HNSCC prediction and intervention.</abstract><keywords/></article-meta></front><body/><back><ref-list><ref id="B1" content-type="article"><label>1</label><element-citation publication-type="journal"><p>Zhou T, Huang W, Wang X, et al., 2024, Global Burden of Head and Neck Cancers from 1990 to 2019. iScience, 27(3): 109282.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B2" content-type="article"><label>2</label><element-citation publication-type="journal"><p>Barsouk A, Aluru J, Rawla P, et al., 2023, Epidemiology, Risk Factors, and Prevention of Head and Neck Squamous Cell Carcinoma. Medical Sciences (Basel, Switzerland), 11(2): 42.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B3" content-type="article"><label>3</label><element-citation publication-type="journal"><p>Jin H, Wang J, Wang Z, et al., 2023, Lipid Metabolic Reprogramming in Tumor Microenvironment: From Mechanisms to Therapeutics. Journal of Hematology &amp; Oncology, 16(1): 103.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B4" content-type="article"><label>4</label><element-citation publication-type="journal"><p>Liu R, Wang C, Tao Z, et al., 2025, Lipid Metabolism Reprogramming in Cancer: Insights into Tumor Cells and Immune Cells within the Tumor Microenvironment. Biomedicines, 13(8): 1895.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B5" content-type="article"><label>5</label><element-citation publication-type="journal"><p>Cioce M, Arbitrio M, Polerà N, et al., 2024, Reprogrammed Lipid Metabolism in Advanced Resistant Cancers: An Upcoming Therapeutic Opportunity. Cancer Drug Resistance (Alhambra, Calif.), 7: 45.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B6" content-type="article"><label>6</label><element-citation publication-type="journal"><p>Liang J, Li L, Li L, et al., 2023, Lipid Metabolism Reprogramming in Head and Neck Cancer. Frontiers in Oncology, 13: 1271505.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B7" content-type="article"><label>7</label><element-citation publication-type="journal"><p>Huang Y, Xiao X, Sadeghi F, et al., 2023, Blood Metabolic Biomarkers and the Risk of Head and Neck Cancer: An Epidemiological Study in the Swedish AMORIS Cohort. Cancer Letters, 557: 216091.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B8" content-type="article"><label>8</label><element-citation publication-type="journal"><p>Wang S, Wang L, Li H, et al., 2024, Correlation Analysis of Plasma Lipid Profiles and the Prognosis of Head and Neck Squamous Cell Carcinoma. Oral Diseases, 30(2): 329–341.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B9" content-type="article"><label>9</label><element-citation publication-type="journal"><p>Wilms T, Boldrup L, Gu X, et al., 2021, High Levels of Low-Density Lipoproteins Correlate with Improved Survival in Patients with Squamous Cell Carcinoma of the Head and Neck. Biomedicines, 9(5): 506.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B10" content-type="article"><label>10</label><element-citation publication-type="journal"><p>Feng J, Zhao J, Yang X, et al., 2021, The Prognostic Impact of Preoperative Serum Apolipoprotein A-I in Patients with Esophageal Basaloid Squamous Cell Carcinoma. Cancer Management and Research, 13: 7373–7385.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B11" content-type="article"><label>11</label><element-citation publication-type="journal"><p>Elsworth B, Lyon M, Alexander T, et al., 2020, The MRC IEU OpenGWAS Data Infrastructure. bioRxiv, 2020.08.10.244293v1.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B12" content-type="article"><label>12</label><element-citation publication-type="journal"><p>McLaren W, Gil L, Hunt SE, et al., 2016, The Ensembl Variant Effect Predictor. Genome Biology, 17(1): 122.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B13" content-type="article"><label>13</label><element-citation publication-type="journal"><p>Zhou Y, Zhou B, Pache L, et al., 2019, Metascape Provides a Biologist-Oriented Resource for the Analysis of Systems-Level Datasets. Nature Communications, 10(1): 1523.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B14" content-type="article"><label>14</label><element-citation publication-type="journal"><p>Tang Z, Kang B, Li C, et al., 2019, GEPIA2: An Enhanced Web Server for Large-Scale Expression Profiling and Interactive Analysis. Nucleic Acids Research, 47(W1): W556–W560.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B15" content-type="article"><label>15</label><element-citation publication-type="journal"><p>Cui H, Zhao G, Lu Y, et al., 2025, TIMER3: An Enhanced Resource for Tumor Immune Analysis. Nucleic Acids Research, 53(W1): W534–W541. https://doi.org/10.1093/nar/gkaf388</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B16" content-type="article"><label>16</label><element-citation publication-type="journal"><p>Cerami E, Gao J, Dogrusoz U, et al., 2012, The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discovery, 2(5): 401–404.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B17" content-type="article"><label>17</label><element-citation publication-type="journal"><p>Burgess S, Bowden J, Fall T, et al., 2017, Sensitivity Analyses for Robust Causal Inference from Mendelian Randomization Analyses with Multiple Genetic Variants. Epidemiology (Cambridge, Mass.), 28(1): 30–42.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B18" content-type="article"><label>18</label><element-citation publication-type="journal"><p>Malik D, David R, Gooderham N, 2018, Ethanol Potentiates the Genotoxicity of the Food-Derived Mammary Carcinogen PhIP in Human Estrogen Receptor-Positive Mammary Cells: Mechanistic Support for Lifestyle Factors (Cooked Red Meat and Ethanol) Associated with Mammary Cancer. Archives of Toxicology, 92(4): 1639–1655.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B19" content-type="article"><label>19</label><element-citation publication-type="journal"><p>An Y, Chen X, Yang Y, et al., 2018, LncRNA DLX6-AS1 Promoted Cancer Cell Proliferation and Invasion by Attenuating the Endogenous Function of miR-181b in Pancreatic Cancer. Cancer Cell International, 18: 143.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B20" content-type="article"><label>20</label><element-citation publication-type="journal"><p>National Toxicology Program, 2021, 15th Report on Carcinogens. National Toxicology Program, Research Triangle Park (NC). Acetaldehyde: CAS No. 75-07-0, visited on June 12, 2025, https://www.ncbi.nlm.nih.gov/books/NBK590821/?utm_source=chatgpt.com</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B21" content-type="article"><label>21</label><element-citation publication-type="journal"><p>Creamer K, Larsen E, Lawrence J, 2022, ZNF146/OZF and ZNF507 Target LINE-1 Sequences. G3 (Bethesda, Md.), 12(3): jkac002.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B22" content-type="article"><label>22</label><element-citation publication-type="journal"><p>Yukawa Y, Muto M, Hori K, et al., 2012, Combination of ADH1B2/ALDH22 Polymorphisms Alters Acetaldehyde-Derived DNA Damage in the Blood of Japanese Alcoholics. Cancer Science, 103(9): 1651–1655.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B23" content-type="article"><label>23</label><element-citation publication-type="journal"><p>Chien H, Tsai C, Young C, et al., 2023, Single-Nucleotide Polymorphism at Alcohol Dehydrogenase 1B: A Susceptible Gene Marker in Oro-/Hypopharyngeal Cancers from Genome-Wide Association Study. Cancer Medicine, 12(18): 19174–19187.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B24" content-type="article"><label>24</label><element-citation publication-type="journal"><p>Heravi G, Jang H, Wang X, et al., 2022, Fatty Acid Desaturase 1 (FADS1) Is a Cancer Marker for Patient Survival and a Potential Novel Target for Precision Cancer Treatment. Frontiers in Oncology, 12: 942798.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B25" content-type="article"><label>25</label><element-citation publication-type="journal"><p>Gong Q, Li H, Song J, et al., 2023, LncRNA LINC01569 Promotes M2 Macrophage Polarization to Accelerate Hypopharyngeal Carcinoma Progression through the miR-193a-5p/FADS1 Signaling Axis. Journal of Cancer, 14(9): 1673–1688.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B26" content-type="article"><label>26</label><element-citation publication-type="journal"><p>Xuan Y, Wang H, Yung M, et al., 2022, SCD1/FADS2 Fatty Acid Desaturases Equipoise Lipid Metabolic Activity and Redox-Driven Ferroptosis in Ascites-Derived Ovarian Cancer Cells. Theranostics, 12(7): 3534–3552.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B27" content-type="article"><label>27</label><element-citation publication-type="journal"><p>Saleh H, Liloglou T, Rigden D, et al., 2024, KH-Like Domains in PARP9/DTX3L and PARP14 Coordinate Protein-Protein Interactions to Promote Cancer Cell Survival. Journal of Molecular Biology, 436(4): 168434.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B28" content-type="article"><label>28</label><element-citation publication-type="journal"><p>Liu Z, Meng X, Zhang Y, et al., 2024, FUT8-Mediated Aberrant N-Glycosylation of SEMA7A Promotes Head and Neck Squamous Cell Carcinoma Progression. International Journal of Oral Science, 16(1): 26.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B29" content-type="article"><label>29</label><element-citation publication-type="journal"><p>Seidensaal K, Nollert A, Feige A, et al., 2015, Impaired Aldehyde Dehydrogenase 1 Subfamily Member 2A-Dependent Retinoic Acid Signaling Is Related with a Mesenchymal-Like Phenotype and an Unfavorable Prognosis of Head and Neck Squamous Cell Carcinoma. Molecular Cancer, 14: 204.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B30" content-type="article"><label>30</label><element-citation publication-type="journal"><p>Mao C, Zhou X, Jiang Y, et al., 2020, The Evi5 Oncogene Promotes Laryngeal Cancer Cells Proliferation by Stabilizing c-Myc Protein. Cancer Cell International, 20: 44.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B31" content-type="article"><label>31</label><element-citation publication-type="journal"><p>Gao M, Zhang W, Li X, et al., 2025, LCAT in Cancer Biology: Embracing Epigenetic Regulation, Immune Interactions, and Therapeutic Implications. International Journal of Molecular Sciences, 26(4): 1453.</p><pub-id pub-id-type="doi"/></element-citation></ref></ref-list></back></article>
